Estratto
L’anafilassi è la più grave delle reazioni allergiche, è potenzialmente mortale, ed è pertanto necessario riconoscerla e mettere in atto tempestivamente le manovre previste, somministrando il trattamento farmacologico appropriato, poiché la rapidità dell’intervento è fondamentale ai fini dell’efficacia della terapia.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Bibliografia
Sampson HA (2003) Anaphylaxis and emergency treatment. Pediatrics 111:1601–1608
Lieberman P, Kemp SF, Oppenheimer J et al (2005) The diagnosis and management of anaphylaxis: an updated practice parameter. J Allergy Clin Immunol 115:s483–s523
Walker S, Sheikh A (2003) Managing anaphylaxis: effective emergency and long-term care are necessary. Clin Exp Allergy 33:1015–1018
Project Team of The Resuscitation Council (UK) (2001) Update on the emergency medical treatment of anaphylactic reactions for first medical responders and for community nurses. Resuscitation 48:241–243
Simons FER, Gu X, Simons KJ (2001) Epinephrine absorption in adults: intramuscular versus subcutaneous injection. J Allergy Clin Immunol 108:871–873
Sampson HA, Munoz-Furlong A, Campbell RL et al (2006) Second symposium on the definition and management of anaphylaxis; summary report. Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol 117:391–397
American Academy of Allergy and Immunology Board of Directors (1994) The use of epinephrine in the treatment of anaphylaxis. J Allergy Clin Immunol 94:666–668
American Academy of Allergy, Asthma, & Immunology website (2003) Available at website: http://www.aaaai.org/patients/publicedmat/tips/what/isanaphylaxis.stm. Accessed June 20, 2003
Fan HW, Marcopito LF, Cardoso JL et al (1999) Sequential randomised and double blind trial of promethazine prophylaxis against early anaphylactic reactions to antivenom for bothrops snake bites. Brit Med J 318:1451–1452
Clark AT, Ewan PW (2002) The prevention and management of anaphylaxis in children. Current Paediatrics 12:370–375
Ministero della Salute (2003) Guida all’uso dei farmaci per i bambini. Ministero della Salute, Roma
Lin RY, Curry A, Pesola GR et al (2000) Improved outcomes in patients with acute allergic syndromes who are treated with combined H1 and H2 antagonists. Ann Emerg Med 36:462–468
Runge JW, Martinez JC, Caravati EM et al (1992) Histamine antagonists in the treatment of acute allergic reactions. Ann Emerg Med 21:237–242
Toogood JH (1988) Risk of anaphylaxis in patients receiving beta-blocker drugs. J Allergy Clin Immunol 81:1–3
Thomas M, Crawford I (2005) Best evidence topic reports: glucagon infusion in refractory anaphylactic shock in patients on beta-blockers. Emerg J Med 22:272–276
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer-Verlag Italia
About this chapter
Cite this chapter
Calvani, M., Cardinale, F., Martelli, A., Muraro, M.A., Pucci, N., Savino, F. (2007). Terapia. In: Calvani, M., Cardinale, F., Martelli, A., Muraro, M.A., Pucci, N., Savino, F. (eds) Anafilassi in pediatria. Springer, Milano. https://doi.org/10.1007/978-88-470-0621-8_12
Download citation
DOI: https://doi.org/10.1007/978-88-470-0621-8_12
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-0620-1
Online ISBN: 978-88-470-0621-8
eBook Packages: MedicineMedicine (R0)